Ultragenyx Pharmaceutical reports double-digit rise in revenue for Q3
The Marin County developer of treatments for rare diseases noted that its treatment for a form of rickets has been driving sales.
The Marin County developer of treatments for rare diseases noted that its treatment for a form of rickets has been driving sales.
According to the WHO, about 40 percent of pharmaceutical products are based on natural sources, and 70 percent of people worldwide rely on traditional medicines. The use of approximately 50,000-80,000 plant species for medicinal purposes worldwide …
With the rise in global counterfeiting operations, stakeholders need to be aware of their responsibility when it comes to pharmaceutical goods and their legitimacy. Companies can make this task easier by adopting cloud-based serialisation and standardised barcoding to prevent counterfeit goods from entering the market.
Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with relapsed or refractory solid tumours. The study involved patients who had undergone an average of three previous lines of treatment.
Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit forecasts, boosted by strong sales of copycat medicines and its branded drugs to treat migraines and Huntington’s disease.
Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs straight to the consumers who want them.
STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.
BISMARCK, N.D. (KFGO) – North Dakota Attorney General Drew Wrigley says 50 states and territories have made significant settlements and cooperation agreements with Heritage Pharmaceuticals and Apotex totaling $49 million.
Vance told Joe Rogan during his appearance on his podcast that he’d “look into” pursuing Congressional support to regulate advertising by pharmaceutical companies. “If there was one thing that we could do to rein in the pharmaceutical companies …
This settlement foreshadows the first court trial in this series of anti-trust price fixing investigations into the generic drug industry.